Recent Advances in Cancer Research and Therapy (eBook)

Xin-Yuan Liu, Sidney Pestka, Yu-Fang Shi (Herausgeber)

eBook Download: PDF | EPUB

2012 | 1. Auflage
700 Seiten
Elsevier Science (Verlag)
978-0-12-397836-3 (ISBN)

Infos

Cancer continues to be one of the major causes of death throughout the developed world, which has led to increased research on effective treatments. Because of this, in the past decade, rapid progress in the field of cancer treatment has been seen. Recent Advances in Cancer Research and Therapy reviews in specific details some of the most effective and promising treatments developed in research centers worldwide. While referencing advances in traditional therapies and treatments such as chemotherapy, this book also highlights advances in biotherapy including research using Interferon and Super Interferon, HecI based and liposome based therapy, gene therapy, and p53 based cancer therapy. There is also a discussion of current cancer research in China including traditional Chinese medicine. Written by leading scientists in the field, this book provides an essential insight into the current state of cancer therapy and treatment. - Includes a wide range of research areas including a focus on biotherapy and the development of novel cancer therapeutic strategies. - Formatted for a broad audience including all working in researching cancer treatments and therapies. - Discusses special traits and results of Chinese cancer research.

Textauszug

List of Contributors

Ying Cai Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Xin Cao Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Chi-Hong Chao Department of Molecular and Cellular Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX

Kai-Xian Chen Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Kun Chen Cancer Institute, Zhejiang University, Hangzhou, People’s Republic of China

Yi Chen Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Liang Chu Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China; Washington University in St. Louis, School of Medicine, St. Louis, MO

Jian Ding Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Miao Ding Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Zhen-Yu Ding Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan, People’s Republic of China

Qi Dong Cancer Institute, Zhejiang University, Hangzhou, People’s Republic of China

Jing Fan State Key Laboratory of Molecular Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Jun-Kai Fan Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Erin M. Goldblatt Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA

Jin-Fa Gu Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Jennifer L. Hsu Department of Molecular and Cellular Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX; Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University and Hospital, Taichung, Taiwan; Asia University, Taichung, Taiwan

He Huang Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Jing-Yu Huang First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan Province, People’s Republic of China

Wenlin Huang State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China

Wen-Lin Huang Cancer Center, Sun Yat-sen University, Guangzhou, People’s Republic of China

Mien-Chie Hung Department of Molecular and Cellular Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX; Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University and Hospital, Taichung, Taiwan; Asia University, Taichung, Taiwan

Hong-Bin Ji Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Jing Jiang State Key Laboratory of Molecular Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China

Yu-Juan Jin Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Ronald G. Jubin UMDNJ-Robert Wood Johnson Medical School, Department of Molecular Genetics Microbiology and Immunology, Piscataway, NJ

Doranelly H. Koltchev UMDNJ-Robert Wood Johnson Medical School, Department of Molecular Genetics Microbiology and Immunology, Piscataway, NJ

Eva Lee Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA

Wen-Hwa Lee Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA

Cui-Ping Li Department of Transfusion, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, People’s Republic of China; Department of Transfusion, the Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, People’s Republic of China

Huang-Guang Li Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Xiao Li Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, People’s Republic of China

Anning Lin Ben May Department for Cancer Research, The University of Chicago, Chicago, IL

Hong Liu Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Hua Liu Cancer Biotherapy Research Laboratory, Zhong Shan Hospital, Fudan University, and Stem Cell Research Laboratory, Min Hang Hospital, Rui Jin Hospital Group, Jiao Tong University, Shanghai, People’s Republic of China

Jing Liu Ben May Department for Cancer Research, The University of Chicago, Chicago, IL; Division of Pulmonary and Critical Care Medicine, Feinberg School of Medicine, Northwestern Univerisity, Chicago, IL

Jing-Yuan Liu Department of Pharmacology and Toxicology and IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN

Leroy F. Liu Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School and The Cancer Institute of New Jersey, Piscataway, NJ

Lun-Xu Liu Department of Thoracic Surgery, West China Hospital, Chengdu, People’s Republic of China

Qiang Liu Department of Breast Surgery, Sun-Yat-Sen Memorial Hospital, Sun-Yat-Sen University, Guangzhou, People’s Republic of China; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Xin-Ran Liu Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Xin-Yuan Liu Laboratory of Molecular Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai, People’s Republic of China; Hui-Yang Life Science and Technology Corp., Chengdu, People’s Republic of China; Xinyuan Institute of Medicine and Biotechnology, College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou, People’s Republic of China

Yao-Hua Liu Department of Pharmacology, Harbin Medical University, Harbin, People’s Republic of China

Xin Lu Ludwig Institute for Cancer Research Oxford Branch, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK

You-Yong Lu Laboratory of Molecular Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital/Institute, Beijing, P.R. China

Xiao-Min Luo Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Yi Lisa Lyu Department of Pharmacology, UMDNJ-Robert Wood Johnson Medical School and The Cancer Institute of New Jersey, Piscataway, NJ

Lin Ma Department of Thoracic Surgery, West China Hospital, Chengdu, People’s Republic of China

Ze-Hong Miao Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of China

Wei Mo Department of Pharmacology and Toxicology and IU Simon Cancer Center, Indiana University School of Medicine, Indianapolis,...

Produkt-Details

• Erscheint lt. Verlag: 18.5.2012
• Sprache: englisch
• Themenwelt: Medizin / Pharmazie ► Allgemeines / Lexika
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
• Themenwelt: Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
• Themenwelt: Studium ► Querschnittsbereiche ► Epidemiologie / Med. Biometrie
• Themenwelt: Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie
• Themenwelt: Technik
• ISBN-10: 0-12-397836-X / 012397836X
• ISBN-13: 978-0-12-397836-3 / 9780123978363